Standout Papers

Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials 2023 2026 202481
  1. Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials (2023)
    Jonathan Corren, Andrew Menzies‐Gow et al. American Journal of Respiratory and Critical Care Medicine

Immediate Impact

58 by Nobel laureates 28 from Science/Nature 74 standout
Sub-graph 1 of 24

Citing Papers

Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
2025 Standout
Refining the impact of genetic evidence on clinical success
2024 StandoutNature
1 intermediate paper

Works of Christopher S. Ambrose being referenced

Clinical response and on-treatment clinical remission with tezepelumab in a broad population of patients with severe, uncontrolled asthma: results over 2 years from the NAVIGATOR and DESTINATION studies
2024
An expert consensus framework for asthma remission as a treatment goal
2019
and 1 more

Author Peers

Author Last Decade Papers Cites
Christopher S. Ambrose 2836 816 849 817 148 4.0k
James G. Donahue 2653 681 483 1319 98 5.7k
Lone Graff Stensballe 1276 464 945 588 92 2.9k
Fred Zepp 2311 802 439 857 194 5.3k
Joseph B. Domachowske 3598 883 1536 1345 168 5.8k
Johannes G. Liese 2369 128 703 791 128 4.2k
Paul Gargiullo 3665 383 217 1839 72 5.8k
Jussi Mertsola 4981 263 861 1118 181 6.9k
Flor M. Muñoz 3736 117 600 1669 201 6.6k
Chiara Azzari 2655 170 432 710 249 4.9k
Adrian R. Martineau 1341 931 655 2036 141 6.2k

All Works

Loading papers...

Rankless by CCL
2026